Cocrystal Pharma COCP
NASDAQ COCP
$1.12 -0.10 (-8.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Share-based Compensation (2013 - 2026)

Updated

Cocrystal Pharma's Share-based Compensation came in at $92,000 for Q2 2026, up 9.5% from $84,000 a year earlier and up 9.5% from the prior quarter.

Analysis

Cocrystal Pharma (COCP) Share-based Compensation (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cocrystal Pharma reported Share-based Compensation of $280,000, down 44.4% year-over-year; for FY2025, it came in at $270,000, down 58.0% from FY2024.

  • Share-based Compensation has declined in each of the last three years, with a five-year compound annual growth rate of -16.4% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $643,000 in FY2024 (-19.7%), $801,000 in FY2023 (-6.3%), $855,000 in FY2022 (+18.1%) and $724,000 in FY2021 (+9.4%).
  • The Q2 2026 figure represents the highest quarterly Share-based Compensation since Q3 2024.
  • Year-over-year, Share-based Compensation increased in three of the last eight quarters, with an average decline of 24.3%.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q2 2022 (growth of 209.0%), and the weakest in Q3 2025 (a decline of 81.0%).
  • Business Quant data shows COCP's Share-based Compensation at $84,000 (Q1 2026), $56,000 (Q4 2025) and $48,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Cocrystal Pharma 16.68 Mn -5.22 Mn - 92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92,000.00
Mar 31, 2026 84,000.00
Dec 31, 2025 56,000.00
Sep 30, 2025 48,000.00
Jun 30, 2025 84,000.00
Mar 31, 2025 82,000.00
Dec 31, 2024 85,000.00
Sep 30, 2024 253,000.00
Jun 30, 2024 148,000.00
Mar 31, 2024 157,000.00
Dec 31, 2023 158,000.00
Sep 30, 2023 173,000.00
Jun 30, 2023 179,000.00
Mar 31, 2023 291,000.00
Dec 31, 2022 159,000.00
Sep 30, 2022 216,000.00
Jun 30, 2022 241,000.00
Mar 31, 2022 239,000.00
Dec 31, 2021 222,000.00
Sep 30, 2021 205,000.00
API Access

Cocrystal Pharma Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=COCP&period=max&api_key=YOUR_API_KEY